Trial intelligence / Profile preview

Bioequivalence of Generic Pimecrolimus Cream vs Elidel in Atopic Dermatitis

NCT02791308Phase 3Completed

Sponsor
Allergan
Start
Feb 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Pimecrolimus vehicle + topical corticosteroid in atopic dermatitis (AD), sponsored by Allergan. Started Feb 2015; status: completed.

02

Drugs

Pimecrolimus vehicle + topical corticosteroid
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT02791308.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02791308.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call